| Execution period | quarter ended 31st March, 2026 |
|---|
BSE filing, NSE: THEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Themis Medicare Ltd: key numbers
- Share price
- ₹94.83
- Market cap
- ₹873.4 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 21.9×Sector 48.7×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Board Meeting Date
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Themis Medicare Credit Rating
CARE Ratings downgraded Themis Medicare's long-term and short-term bank facility ratings. The downgrade reflects deteriorating profitability, heightened competition, and weak debt coverage indicators.
Other other announcement announcements
All →Narayana Hrudayalaya Other Announcement
Narayana Hrudayalaya filed a Regulation 54 security cover statement for the quarter ended September 30, 2026. The NCDs are unsecured, so the cover requirement does not apply.
Lyka Labs Other Announcement
Lyka Labs filed its quarterly shareholding pattern for the period ended September 30, 2026 under Regulation 31. Promoter and public holdings are reported as of that date, with no transaction or corporate event.
Mobavenue AI Tech Other Announcement
Mobavenue AI Tech filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 65.6% of the equity.
IITL Projects Other Announcement
IITL Projects confirmed it need not file Regulation 23 related party disclosures for the half-year ended 30 September 2026. The small-company exemption applies under Regulation 15(2).
Radiowalla Network Other Announcement
Radiowalla Network said Regulation 23(9) related party disclosure does not apply to it as an SME-listed company. The company will continue complying with other listing requirements.
Varvee Global Other Announcement
Varvee Global Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. It is a routine disclosure with no transaction or new money.